Total Funding
63
3
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
135953
ClexBio, we envision a world where no patient needs to die while waiting for an organ transplant.
- Manuel Schweikle: CSO & Co-Founder
- Armend G. Håti: CEO & Co-Founder
About the Company
ClexBio is a pre-clinical stage regenerative medicine company that has developed a ground-breaking proprietary technology platform for scalable, high-throughput tissue generation. ClexBio holds patents for a highly innovative method for producing biocompatible hydrogels, as well as the technology for growing large tissues from healthy human cells
in complex geometric shapes.
